Elucidating the exact pharmacological mechanism of motion (MOA) of naturally taking place compounds may be difficult. While Tarselli et al. (60) formulated the initial de novo artificial pathway to conolidine and showcased this naturally taking place compound proficiently suppresses responses to the two chemically induced and inflammation-derived p